Athyrium Opportunities II Co-Invest 1 LP

This profile gathers the share dealings of Athyrium Opportunities II Co-Invest 1 LP in HLS Therapeutics Inc. The record holds 4 filings, for trades running from 12 March 2018 to 30 June 2023.

On the market, this insider has only sold: 1 sale, €5.2M in total. The rest of the record consists of 1 option exercise. 2023 to date brings no purchases and 1 sale.

The newest entry dates from 4 July 2023: an open-market sale of €5.2M, in HLS Therapeutics Inc. The median gap between a trade and its publication by SEDI is 3 days. The shorter that gap, the sooner other investors can see what insiders have done. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. Every figure here comes from the filings published by SEDI and describes the past, not future prices; it is not investment advice.